Overview

This trial is active, not recruiting.

Condition diabetes mellitus
Sponsor Naestved Hospital
Start date April 2010
Trial size 80 participants
Trial identifier NCT00985101, SJ-109

Summary

The purpose of this study is to examine if an early detectable dysfunction in a cellular component (mitochondria) may predict complications in diabetes mellitus.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model case control
Arm

Primary Outcomes

Measure
endothelial damage
time frame: 3 times pr years

Eligibility Criteria

Male or female participants from 18 years up to 90 years old.

Inclusion Criteria: - Diabetes mellitus Exclusion Criteria: - Age below 18 yrs - Psychiatric disease - Other metabolic disease

Additional Information

Official title Study of the Significance of Mitochondrial Dysfunction for Development of Diabetic Complications
Trial information was received from ClinicalTrials.gov and was last updated in July 2010.
Information provided to ClinicalTrials.gov by Naestved Hospital.